Pharmacologic boosting of atazanavir in maintenance HIV-1 therapy: the COREYA propensity-score adjusted study.

Pharmacologic boosting of atazanavir in maintenance HIV-1 therapy: the COREYA propensity-score adjusted study.

BACKGROUND: Among HIV-1 infected patients who achieved virologic suppression, the use of atazanavir without pharmacologic boosting is debated. We evaluated the efficacy and tolerance of maintenance therapy with unboosted atazanavir in clinical practice. METHODS AND RESULTS: This multicenter retrospe...

Full description

Bibliographic Details
Main Authors: Laurent Hocqueloux, Philippe Choisy, Gwenaël Le Moal, Françoise Borsa-Lebas, David Plainchamp, Eric Legac, Thierry Prazuck, Xavier de la Tribonnière, Yazdan Yazdanpanah, Jean-Jacques Parienti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3494679?pdf=render

Internet

http://europepmc.org/articles/PMC3494679?pdf=render

Similar Items